We provide you with 20 years of free, institutional-grade data for AXGN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AXGN. Explore the full financial landscape of AXGN stock.
| Reported Date | CIK | Ticker | Type |
|---|
AxoGen, Inc(NASDAQ:AXGN) 
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without th...
Website: http://www.axogeninc.com
Founded: 2002
Full Time Employees: 371
Sector: Healthcare
Industry: Medical Devices
The information provided in this report about AXGN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.